Meet our Team
Mr. Bruce joined Crystal Diagnostics in January of 2012 as a marketing consultant. After a brief stint as the company’s COO, Mr. Bruce became President and CEO in September of 2012. He came to CDx as Principal of Bruce Consulting LLC, a Boulder based marketing solutions company in the biotech space.
Mr. Bruce began his career as a Meat Packaging Product Manager and later Marketing Manager for W.R. Grace in New Zealand. He was promoted to International Market Development Manager for WR Grace, covering Australia, New Zealand, Asia, Latin America, and South Africa. Mr. Bruce left WR Grace to lead the American Lamb Council, and formed a “case-ready”, branded, meat company in Austin Texas. He has served as President and CEO of several biotech companies, both public and private, including CV Technologies Inc., Madaus – North America, Sciona, Inc., and Natrix International LLC.
Mr. Bruce attended high school in Australia, completed his BA and MBA degrees at the University of Georgia and studied and lectured at Massey University in New Zealand.
Chief Operating Officer
Mr. Minardi has been involved in designing and manufacturing hundreds of consumer, commercial and medical products for over three decades. These products include a proprietary IR nuclear imaging controller, an RF personal tracking system, a low profile mammography system, and a neurological muscle stimulator. He was directly involved in the filing of over 50 patent applications, including numerous provisionals.
From 1980 to 1996, Mr. Minardi served for a few companies as either Senior Design Engineer or Director of Product Development, responsible for software and hardware designs, as well as RF security products and systems for medical, residential and commercial applications.
Mr. Minardi co-founded Clear Blue Engineering in 1996 and served as President from its inception to 2006. Clear Blue Engineering, a contract engineering and manufacturing company, was recognized by Deloitte and Touche as one of the top 50 Colorado Technology companies four consecutive years (2002 – 2005), and in 2002, recognized as one of the top 500 technology companies nationwide.
In 2000, Mr. Minardi worked with liquid crystal technology initially developed by Northeast Ohio Medical University and Kent State University. In 2006, he co-founded Pathogen Systems, now known as Crystal Diagnostics.
Chief Financial Officer
Mr. Williams joined Crystal Diagnostics in September 2012. He began his career at Arthur Anderson after graduating from The University of Colorado Leeds School of Business with a Bachelor’s Degree in Finance and Accounting. After two years in public accounting, he served as Assistant to the Controller for NBI, Inc., a hi-tech public (NYSE) computer company and was responsible for accounting and financial statements preparation and analysis. Mr. Williams left NBI and started an all-natural dried fruit distribution company, Vitarian Foods. Vitarian sourced, marketed and distributed products within ten stores in Colorado and ultimately he sold the business to Alfalfas Market. Subsequent to Vitarian, Mr. Williams invested in another start-up, Amrion, Inc. which was a Boulder based manufacturer and marketer of Nutritional Supplements and Vitamins. Mr. Williams served as CFO and managed the rapid growth of Amrion from $1M to $85M in sales in 10 years, overseeing finance, HR and operations which included the building of a 50,000 sq. ft. manufacturing and distribution facility. He managed a successful IPO and a secondary stock offering, before selling to Whole Foods for $165M.
In 2000, Mr. Williams took over a failing assisted living center from a developer, completed the construction and reached full occupancy of 55 residents in two years. This facility is currently operating with significant positive cash flow and rated by the Colorado Department of Health as the one of the top assisted living centers in the state.
Dr. Gary Niehaus
Dr. Niehaus is Professor of Physiology in the Department of Integrative Medical Sciences at the Northeast Ohio Medical University. He earned Bachelors and Masters degrees at the University of Missouri-Columbia and his doctorate at the University of Wisconsin-Madison in 1977.
After a post-doctorial fellowship and entry faculty position at the Albany Medical College in Albany New York, he joined the Northeast Ohio Medical University in 1985. He published over 20 manuscripts investigating the mechanisms by which bacterial infections injure the human lung.
In 2000, as an outgrowth of his studies of bacteria induced injury to the body, Dr. Niehaus established a multidisciplinary research focus group to develop a technology capable of rapidly detecting biologic pathogens such as bacteria and virus. The related research has been reported in 7 scientific meetings and/or publications. The intellectual property created by the research group is the core technology for the Crystal Diagnostics’ CDx detection system.
Dr. Niehaus is the inventor or co-inventor on six patents related to the technology. As Principal Investigator or Co-Investigator, he has acquired over four million dollars in extramural funding to support development of the CDx core technology. In 2006, Dr. Niehaus was appointed as Crystal Diagnostics’ Chief Scientist.